The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) announced today a new collaboration with Danaher Corporation (Danaher), a global science and technology innovator who will provide Cepheid’s Xpert® MTB/RIF Ultra diagnostic test cartridges for tuberculosis (TB) at the price of US$7.97, a 20% reduction from the current price of US$9.98. Danaher has committed to providing these test cartridges at its own cost and states that it will earn no profit from these sales. The agreement between Global Fund and Cepheid also covers improved service and maintenance arrangements and is expected to expand access to millions more high-quality TB tests for people living in low- and middle-income countries where the demand is most pressing.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Time for $5: GeneXpert diagnostic tests | 0 | 764 | December 12, 2019 | |
| Open Letter to Cepheid - For Endorsement - Time to Lower the Price of Xpert Cartridges to US$ 5 | 0 | 534 | October 15, 2019 | |
| Global Fund, USAID and Stop TB Partnership's New Collaboration With Molbio Diagnostics Will Increase Access to Rapid Molecular Tests for TB | 0 | 290 | March 10, 2023 | |
| Substantial Public Investments in GeneXpert Underscore Need for Affordable Pricing | 0 | 345 | September 2, 2021 | |
| Can the High Sensitivity of Xpert MTB/RIF Ultra Be Harnessed to Save Cartridge Costs? | 0 | 319 | February 15, 2020 |